Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
25 Jun 2025$PSTV led today rally with an eye-popping 68% gain after Plus Therapeutics received FDA clearance to begin a Phase 1/2a clinical trial of REYOBIQ its novel therapy targeting childhood brain cancer. Backed by a $3 million Department of Defense grant, the announcement ignited massive trading volume, more than 45x its average as traders rushed in on hopes of both regulatory progress and future funding. For a penny stock, this kind of catalyst FDA green light and government support is a powerful ignition source.
$QS shot up 31% as QuantumScape unveiled a major breakthrough: its “Cobra” separator process, a leap forward in solid-state battery production. Investors cheered this milestone, viewing it as a crucial step toward commercial viability. The stock saw nearly 13x its typical volume, with Wall Street and retail alike betting this is more than just hype. With EV momentum building and analyst coverage heating up, QS may finally be moving from promise to execution.
$GCTK quietly stunned the market with a 26% jump after Glucotrack reported stellar results from its first-in-human study for its long-term implantable Continuous Blood Glucose Monitor. The device showed high accuracy (MARD of 7.7%) with no device-related issues, a strong sign of future viability. Volume exploded from under 80K daily to over 24 million, a testament to how under-the-radar biotech names can erupt when backed by real clinical results and positive data at major medical conferences.
$BMBL surged 25% after announcing a bold restructuring move: a 30% global workforce reduction. This aggressive cost-cutting initiative comes as the online dating space faces fierce competition and evolving user behavior. The return of founder Whitney Wolfe Herd as CEO also boosted investor confidence in a turnaround. With Bumble also upping Q2 guidance, traders clearly see this as a strategic pivot, not desperation.
$AVAV flew 22% higher on the back of a massive earnings beat. AeroVironment crushed both top and bottom-line estimates, posting $275 million in revenue (vs. $242 million expected) and a significant profit surprise. Strong demand for its loitering munitions and growing backlog of $726 million signal robust future growth. The market loved the results and so did analysts, with Raymond James upping the price target to $225. This defense-tech stock is increasingly seen as a long-term winner in a world of rising geopolitical tension.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
